Encentuate joins OATH

TriMed Staff | | Health Imaging | Screening
Provider of enterprise access security systems Encentuate Inc. this week announced that it has joined the Initiative for Open AuTHentication (OATH) with a commitment to deliver OATH compliant enterprise access security products. OATH is a collaborative effort of IT industry leaders aimed at providing architecture for universal strong authentication across all users and devices over all networks, the company said.

Encentuate will use OATH's recently released Reference Architecture v1.0 as a roadmap for making the company's enterprise security access system Encentuate TCI OATH compliant.

TriMed Staff

Related Content

FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise
Singing radiologist pens song to clear up confusion about breast cancer screening recs
AI loaded onto mammography systems can flag possible cancers in real time to speed workflows
Over half of eligible women skip their mammogram

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup